Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuko Kaneda-Nakashima

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
PET Clinics|March 30, 2023
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical ConsiderationsKazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, et al.
International Journal of Molecular Sciences|November 13, 2025
Astatine-211-Labeled Therapy Targeting Amino Acid Transporters: Overcoming Drug Resistance in Non-Small Cell Lung CancerSifan Feng, Kentaro Hisada, Haruna Yorifuji, et al.
International Journal of Molecular Sciences|April 14, 2026
Flavonoid Interactions with Renal Organic Anion Transporters OAT1 and OAT3: Structure-Activity Relationships and Clinical ImplicationsKai Tong, Pinmao Ye, Kazuko Kaneda-Nakashima, et al.
Chembiochem : a European Journal of Chemical Biology|October 26, 2022
Dioxetane Derivative Containing Carboxy Group as a Chemiluminophore-Introducing ReagentYukie Nohara, Shun Masuda, Kazuko Kaneda-Nakashima, et al.
Scientific Reports|August 25, 2023
Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse modelsZitong Shi, Kazuko Kaneda-Nakashima, Ryuichi Ohgaki, et al.
International Journal of Molecular Sciences|September 13, 2025
LAT1-Targeted Alpha Therapy Using <sup>211</sup>At-AAMT for Bone and Soft Tissue SarcomasHaruna Takami, Yoshinori Imura, Hidetatsu Outani, et al.
International Journal of Molecular Sciences|December 23, 2022
Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine SymporterKazuko Kaneda-Nakashima, Yoshifumi Shirakami, Tadashi Watabe, et al.
International Journal of Molecular Sciences|June 26, 2025
L-3-[<sup>18</sup>F]-Fluoro-α-Methyl Tyrosine as a PET Tracer for Tumor Diagnosis: A Systematic Review from Mechanisms to Clinical ApplicationsMei Bao, Xiang Gu, Kai Tong, et al.
Molecular and Cellular Biology|March 22, 2017
Essential Roles of L-Type Amino Acid Transporter 1 in Syncytiotrophoblast Development by Presenting Fusogenic 4F2hcRyuichi Ohgaki, Takahiro Ohmori, Saori Hara, et al.
Translational Oncology|March 30, 2020
Preclinical Evaluation of Radiation-Induced Toxicity in Targeted Alpha Therapy Using [<sup>211</sup>At] NaAt in Mice: A RevisitYuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
PET Clinics|March 30, 2023
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical ConsiderationsKazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, et al.
International Journal of Molecular Sciences|November 13, 2025
Astatine-211-Labeled Therapy Targeting Amino Acid Transporters: Overcoming Drug Resistance in Non-Small Cell Lung CancerSifan Feng, Kentaro Hisada, Haruna Yorifuji, et al.
International Journal of Molecular Sciences|April 14, 2026
Flavonoid Interactions with Renal Organic Anion Transporters OAT1 and OAT3: Structure-Activity Relationships and Clinical ImplicationsKai Tong, Pinmao Ye, Kazuko Kaneda-Nakashima, et al.
Chembiochem : a European Journal of Chemical Biology|October 26, 2022
Dioxetane Derivative Containing Carboxy Group as a Chemiluminophore-Introducing ReagentYukie Nohara, Shun Masuda, Kazuko Kaneda-Nakashima, et al.
Scientific Reports|August 25, 2023
Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse modelsZitong Shi, Kazuko Kaneda-Nakashima, Ryuichi Ohgaki, et al.
International Journal of Molecular Sciences|September 13, 2025
LAT1-Targeted Alpha Therapy Using <sup>211</sup>At-AAMT for Bone and Soft Tissue SarcomasHaruna Takami, Yoshinori Imura, Hidetatsu Outani, et al.
International Journal of Molecular Sciences|December 23, 2022
Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine SymporterKazuko Kaneda-Nakashima, Yoshifumi Shirakami, Tadashi Watabe, et al.
International Journal of Molecular Sciences|June 26, 2025
L-3-[<sup>18</sup>F]-Fluoro-α-Methyl Tyrosine as a PET Tracer for Tumor Diagnosis: A Systematic Review from Mechanisms to Clinical ApplicationsMei Bao, Xiang Gu, Kai Tong, et al.
Molecular and Cellular Biology|March 22, 2017
Essential Roles of L-Type Amino Acid Transporter 1 in Syncytiotrophoblast Development by Presenting Fusogenic 4F2hcRyuichi Ohgaki, Takahiro Ohmori, Saori Hara, et al.
Translational Oncology|March 30, 2020
Preclinical Evaluation of Radiation-Induced Toxicity in Targeted Alpha Therapy Using [<sup>211</sup>At] NaAt in Mice: A RevisitYuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, et al.
Pageof 3